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Abstract
Objective—Schizophrenia patients exhibit impaired working and episodic memory, but this may 
represent generalized impairment across memory modalities or performance deficits restricted to 
particular memory systems in subgroups of patients. Furthermore, it is unclear whether deficits are 
unique from those associated with other disorders.
Method—Healthy controls (n=1101) and patients with schizophrenia (n=58), bipolar disorder 
(n=49) and attention-deficit-hyperactivity-disorder (n=46) performed 18 tasks addressing 
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primarily verbal and spatial episodic and working memory. Effect sizes for group contrasts were 
compared across tasks and the consistency of subjects’ distributional positions across memory 
domains was measured.
Results—Schizophrenia patients performed poorly relative to the other groups on every test. 
While low to moderate correlation was found between memory domains (r=.320), supporting 
modularity of these systems, there was limited agreement between measures regarding each 
individual’s task performance (ICC=.292) and in identifying those individuals falling into the 
lowest quintile (kappa=0.259). A general ability factor accounted for nearly all of the group 
differences in performance and agreement across measures in classifying low performers.
Conclusions—Pathophysiological processes involved in schizophrenia appear to act primarily 
on general abilities required in all tasks rather than on specific abilities within different memory 
domains and modalities. These effects represent a general shift in the overall distribution of 
general ability (i.e., each case functioning at a lower level than they would have if not for the 
illness), rather than presence of a generally low-performing subgroup of patients. There is little 
evidence that memory impairments in schizophrenia are shared with bipolar disorder and ADHD.
Keywords
psychosis; working memory; episodic memory; cognition; bipolar disorder
1. Introduction
Memory impairment is a core feature of schizophrenia (Kahn and Keefe, 2013) related to 
functioning and prognosis (Green et al., 2004). Patients with schizophrenia and their first-
degree relatives demonstrate impairment in working and episodic memory (Agnew-Blais 
and Seidman, 2012; Aleman et al., 1999; Forbes et al., 2009; Snitz et al., 2006; Trandafir et 
al., 2006) and both working memory (Glahn et al., 2003) and episodic memory are 
moderately heritable (Finkel and McGue, 1993; Owens et al., 2011). Thus, memory 
impairments may represent a biomarker of schizophrenia; however, questions about the 
generality of these deficits remain to be addressed.
First, despite group level memory impairment in schizophrenia, measures of memory 
performance are limited as individualized diagnostic classifiers (Glahn et al., 2007; Kern et 
al., 2011). It is unclear whether deficits across memory domains and modalities (e.g., 
working vs. episodic, verbal vs. visuospatial) reflect generalized impairment (Gold and 
Dickinson, 2013), a specific subgroup of patients exhibiting neurocognitive deficits in 
multiple domains (McDermid Vaz and Heinrichs, 2002), or different subsets of patients 
displaying deficits in different domains (Karlsgodt et al., 2011). Previous research in a large 
schizophrenia sample found that cognitive impairment was best explained by a single deficit 
factor (Keefe et al., 2006); however, this study did not include controls and so could not 
directly asses how patterns found in patients compare to typical cognitive structure. A model 
including executive functioning, memory and processing speed best discriminates 
schizophrenia from controls (Lam et al., 2014), which supports the theory that patients with 
schizophrenia are broadly cognitive impaired, but this study included relatively independent 
cognitive tasks and the structure within multiple memory-related tasks has not been 
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measured. Additionally, more refined, cognitive neuroscience-based tasks might better 
identify discrete neurocognitive subsystems that are impaired in patient groups (Carter and 
Barch, 2007).
Second, it is unclear whether memory deficits associated with schizophrenia represent 
biomarkers of risk processes shared with other diagnostic syndromes, such as bipolar 
disorder (Kurtz and Gerraty, 2009) or attention-deficit-hyperactivity-disorder (ADHD)
(Martinussen et al., 2005). While memory impairments in ADHD are likely more 
circumscribed (Castel et al., 2011), impairments in bipolar disorder may be closer to those 
found in schizophrenia, particularly among cases with psychotic symptoms (Glahn et al., 
2006; Hill et al., 2013). Thus, it is important to assess the structure of cognitive dysfunction 
across diagnostic boundaries (Cuthbert and Insel, 2010).
This study sought to clarify the distribution and covariation of impairments across domains 
of memory in patients with schizophrenia and to determine to the extent to which these 
impairments are shared with bipolar disorder and ADHD. The psychiatric comparison 
groups allow us to examine memory impairment in schizophrenia in the context of 
individuals who are hypothesized to share genetic risk architecture with schizophrenia. A 
large reference sample of community volunteers (n=1101) was collected to provide robust 
estimation of the normative distributions of performance on all measures, which included 
both established neuropsychological tasks and experimental tasks designed to isolate 
theoretically separable aspects of working and episodic memory functioning (Carter et al., 
2008).
We hypothesized that among patients with schizophrenia, distributions on all measures of 
memory performance would be shifted downward compared with those of the reference 
population and that there would be consistency in terms of where particular patients scored 
in the distributions across domains and modalities. We further hypothesized that there would 
be a similar distributional shift and cross-distributional consistency among bipolar cases 
with psychotic features, but not among non-psychotic bipolar patients or subjects with 
ADHD.
2. Methods
2.1 Subjects
The study was approved by the Institutional Review Boards of UCLA and Yale University 
and participants provided written informed consent. Subjects were recruited via the UCLA 
Consortium for Neuropsychiatric Phenomics (www.phenomics.ucla.edu). 1101 healthy 
controls (CON) without history of psychosis or ADHD and no current mood or anxiety 
disorders were studied, as well as 58 schizophrenia (SCZ) patients, 49 bipolar (BP) patients, 
and 46 ADHD patients. Participants, aged 21–50, were recruited by community 
advertisements from the Los Angeles area, identified as “White, Not of Hispanic or Latino 
Origin” or “Hispanic or Latino, of Any Race” and completed at least 8 years of education. 
(Other racial and ethnic groups were not recruited to minimize confounding planned genetic 
analyses in the broader study.) Participants were screened for neurological disease, head 
injury with loss of consciousness or cognitive sequelae, or substance dependence within past 
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6 months. Subjects were excluded if urinalysis results were positive for drugs of abuse on 
the day of testing.
2.2 Clinical and Cognitive Assessment
Participants were interviewed using the SCID-IV (First et al., 1995) and patient groups were 
rated on the Hamilton Psychiatric Rating Scale for Depression (HAM-D) (Hamilton, 1960), 
the Scale for the Assessment of Positive and Negative Symptoms (SAPS and SANS) 
(Andreasen, 1983a; 1983b) and the Brief Psychiatric Rating Scale (BPRS) (Overall and 
Gorham, 1962). Participants in the BP group were also differentiated into those with history 
of psychosis, determined by report of positive psychotic symptoms during the SCID 
interview, and those without history of psychosis. Interviewers were trained to criterion 
levels of reliability, which for the SCID involved meeting kappa scores of .85 or greater on 
diagnosis and .75 or greater on symptom and algorithm decisions(Ventura et al., 1998). For 
symptom assessment scales interviewers were trained to a criterion ICC = .80 or greater 
(Ventura et al., 1995).
The neuropsychological testing battery consisted of multiple measures related to memory 
functioning including the California Verbal Learning Test (CVLT) (Delis et al., 2000), 
Visual Reproduction, Symbol Span, Digit Span and Letter-Number Sequencing from the 
Wechsler Memory Scale-IV (Wechsler, 2009). In addition, Vocabulary and Matrix 
Reasoning from the Wechsler Adult Intelligence Scale-IV (Wechsler, 2008), and the Color 
Trails Test (D'Elia et al., 1996) were included as estimates of verbal intelligence, nonverbal 
reasoning and processing speed/cognitive switching, respectively.
During the cognitive testing session subjects also performed computer-based tasks, 
programmed and presented in E-prime®, designed to probe working and episodic memory 
functioning. Remember-Know and Scene Recognition tasks were designed to test verbal and 
visual episodic memory, respectively. Verbal and spatial working memory capacity, 
maintenance and manipulation were also tested. Detailed task descriptions are available in 
the appendix (SA1).
2.3 Statistical Analysis
Statistical analyses were conducted using R (Team, 2015). Group differences on cognitive 
performance were tested using MANOVA followed by univariate ANOVA and Tukey’s 
HSD to clarify patterns of performance in each domain. Effect size (Hedge’s g) was 
calculated to compare the relative size of group effects and linear discriminant analysis with 
leave-one-out cross validation was used to determine how well tasks differentiated between 
groups.
To evaluate whether the same subjects showed impairment across memory domains, we 
examined correlations between the primary performance measures for each task, both in 
terms of their original continuous scaling and in terms of consistency interclass correlations 
of measures transformed into quintile rankings based on the full sample distribution. The 
consistency with which an individual falls in the lowest performance range is of particular 
interest as they are more likely to suffer associated functional impediments. Kappa 
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coefficient of agreement was to measure the consistency of individuals in this lowest 
quintile of performance, where each measure was included as a separate ‘rater’ of 
performance. These measures of consistency were conducted across all tasks as well as 
within a priori defined domains of memory (i.e. working vs. episodic memory and verbal 
vs. spatial memory. See SA2 for a list of tasks in each domain).
Principal component analysis (PCA) was then used to further examine the data. The first 
principal component was determined to represent a general cognitive factor and tested for 
group differences. The residual variance was then tested using the above methods to 
determine how the structure of memory impairments among the subject groups is affected 
by generalized versus task specific effects.
3. Results
3.1 Sample Characteristics
CON and SCZ/BP differed significantly on age and there was a significant difference in the 
proportion of males in SCZ compared with the other groups. Thus, age and gender were 
included as covariates in the group-contrast analyses. There were also significant group 
differences on ethnicity with CON and SCZ having higher percentages of Hispanic 
participants than BP and ADHD. As expected, patient groups differed on ratings of clinical 
variables, with more severe overall psychopathology, positive and negative symptoms in 
SCZ and both SCZ and BP experiencing more depression symptoms than ADHD (Table 1).
3.2 Cognitive Testing Performance
Groups differed significantly on cognitive performance [F(3,989)=4.16, p<.001], age 
[F(1,989)=18.95, p<.001] and gender [F(1,989)=6.93, p<.001], with no significant 
interactions. The group effect was also significant for each measure of test performance at 
the univariate level (Table 1). Moreover, effect sizes revealed a moderate to large deficit for 
SCZ compared to CON, BP and ADHD on all measures, with g > .5 on 14 of the 18 
measures (Table 2).
Frequency distributions (Figure 1) show that the performance of the patient groups generally 
falls within the range of the CON sample. Mean differences appear as an overall downward 
shift of the distributions for the SCZ group and, to a lesser extent, the BP and ADHD 
groups. Furthermore, discriminant analysis was unable to accurately identify patient groups 
when compared to the large reference sample of controls utilized in this study (SA3).
Group differences in memory performance were independent of clinical symptom severity 
(SA4). Few BP participants were currently experiencing psychotic symptoms, but 27 (55%) 
reported a history of positive psychotic symptoms (i.e., hallucinations or delusions on the 
SCID). However, contrary to our hypotheses, there were no significant differences between 
BP subjects with and without history of psychosis on any measure (all p’s > .11).
3.3 Consistency of Impairments
As identification of individuals with clinically relevant cognitive impairments is most 
pertinent for allocating resources such as remediation, the consistency with which an 
Haut et al. Page 5
Schizophr Res. Author manuscript; available in PMC 2016 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
individual falls in the lowest performance range across tasks is of particular interest. Across 
tasks, a large percentage of patients with schizophrenia were in the lowest quintile of the 
overall distribution (Table 2). However, analyses of cross-test agreement in classification of 
subjects in the lowest quintile indicated only modest overlap (Fleiss’ Kappa for m “Raters” 
(tests): Overall = .209; CON=.208; SCZ=.259; BP=.213; ADHD=.215). Restricting analyses 
to a priori classifications of memory domains (SA2) did not produce appreciably higher 
consistency metrics. Overall, kappa for lowest quintile of performance within measures of 
working memory was .221 [CON=.190, SCZ=.275, BP=.311, ADHD=.198], while kappa 
for lowest quintile of performance between measures of working memory and episodic 
memory was .177 [CON=.140, SCZ=.257, BP=.157, ADHD=.224] and between measures of 
working memory and general cognition was .221 [CON=.201, SCZ=.234, BP=.191, 
ADHD=.185]. Similarly, kappa for agreement on lowest quintile of performance within 
measures of episodic memory was .248 [CON=.205, SCZ=.291, BP=.311, ADHD=.256] and 
between measures of episodic memory and general cognition was .189 [CON=.156, SCZ=.
253,BP=.174, ADHD=.177]. Similar results were found when measures were classified as 
either verbal memory or visual memory. While evaluating the consistency with which tests 
identify individuals in the lowest quintile most closely parallels the identification of 
individuals considered to be clinically impaired, this does necessitate collapsing across the 
remaining range of performance. However, test by test consistency statistics, analyses of 
correlations and ICCs for continuous measures of performance across tasks produced highly 
parallel results, with similarly modest agreement and weak support for consistency within 
proposed domains (ST1–5,SA5).
3.4 Principal Component Analysis
Principal component analysis revealed one primary component (PC1) that accounted for 
36.6% of the total variance. All tasks loaded on to this first component, with coefficients 
ranging from .16 for Spatial Manipulation to .29 for Symbol Span (Table 3). There were 
significant group differences on PC1 [F(3,1001)=34.79, p<.001], with SCZ scoring lower 
than CON (g=− 1.53), BP (g=-.95) and ADHD (g=−1.20) and BP scoring lower than CON 
(g=−.42) (Figure 2). Group differences in performance on individual tasks were then 
reassessed using the residuals after regressing out the contribution of PC1 score. Residual 
variance demonstrated a greatly reduced effect size for group differences across tasks (Table 
3), and only CVLT maintained a significant group difference [F(3,1001)=11.45, p<.001]. 
Regressing out PC1 also eliminated the modest levels of agreement for the originally scaled, 
quintile-rescaled, and lowest-quintile kappa metrics across the tasks (ST5).
Despite including primarily memory tests, the general factor identified appears to be 
representative of broader cognitive ability. When non-memory tasks were excluded from the 
PCA, the first principal component among memory measures still correlated highly with 
Vocabulary [r(1003)=.476, p<.001], which is a good approximation of general cognitive 
functioning. However, the memory derived principal component measure continued to show 
group differences even controlling for Vocabulary performance [F(3,1000)=26.01; p<.001].
The effects reported above include age and gender as covariates of non-interest in the 
statistical models, which may not fully account for demographic effects (Miller and J. P. 
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Chapman, 2001). Thus, a subset of 430 controls nearest-neighbor matched to the patient 
group with no demographic group differences (all p > .06) was tested as well and this 
produced results comparable to results including the full sample (SA6).
4. Discussion
Despite moderate to large differences in group means across numerous verbal and spatial 
working and episodic memory tasks, memory performance is limited in its ability to separate 
SCZ from controls or to classify subjects with SCZ, bipolar disorder, and ADHD into 
separate groups. Performance distributions were unimodal, with only modest consistency in 
the membership of the lowest performing quintile of subjects across tasks. Further, variation 
in a general factor common to all tasks accounted for nearly all group differences in 
performance and the inter-correlation among tasks. Together, these results suggest that the 
pathophysiological processes involved in schizophrenia act primarily on general abilities 
required in most tasks rather than on specific abilities within different specific memory 
domains and that these effects represent a shift in the overall distribution (i.e., with each 
case functioning at a lower level than they would have if not for the illness), rather than 
presence of a low-performing subgroup of patients or of multiple subgroups performing 
poorly on different tasks.
That performance on tests tapping into different memory domains (working memory, 
episodic memory) and modalities (verbal, visuospatial) were only modestly correlated (and 
not correlated after controlling for general ability) supports the functional dissociations 
among these divisions within memory systems. Intercorrelations among the different tasks 
were the same among healthy subjects and each of the three patient groups, indicating that 
this modularity is preserved in each of the neuropsychiatric conditions examined.
These results suggest that efforts to isolate discrete subcomponents of memory systems may 
have limited utility in research on the pathophysiology of schizophrenia (Carter and Barch, 
2007). Rather, these results are more consistent with the argument that schizophrenia is 
closely tied to a general underlying deficit (Dickinson et al., 2011; 2008). Similarly, 
controlling for general cognition has been found to account for most deficits in spatial 
working memory across schizophrenia and bipolar probands and relatives (Hill et al., 2015) 
This general deficit may impact cognitive abilities that contribute to most or all memory 
performance parameters, such as the ability to encode and organize information. Variations 
in the level of impairment across particular tasks or components of tasks may be related to 
their reliance on this generalized ability. For example, recollection-based episodic memory 
is relatively more impaired than familiarity-based episodic memory in schizophrenia (Haut 
et al., 2014; van Erp et al., 2008). These findings were replicated in this sample, with SCZ 
showing impairment on R responses [F(3,1127)=3.99, p=.008] and not K responses 
[F(3,1127)=.2750, p=.84] on the R-K task. However, R loaded more strongly on to PC1 than 
K (.15 versus .05) and there were no group differences in the residual variance. Furthermore, 
the effect size of impairment in SCZ trended towards a correlation with the degree that each 
task loaded on to the generalized factor (r=.42, p=.08). Recent neuroanatomical findings also 
suggest systemic abnormalities that are more parsimonious with a general cognitive factor 
explanation (Dickinson and Harvey, 2009).
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One exception to this conclusion may relate to self-generated verbal declarative memory, as 
schizophrenia patients continued to show deficits on the CVLT when controlling for general 
ability. This may be related to task requirements, as the CVLT requires the test taker to self-
generate word list items from memory, whereas most of the other tasks in this study used a 
recognition format in which previously studied items were presented mixed with foils. 
Similarly, this effect may be artifactual due to differential discriminating abilities of the 
tasks (e.g. specific psychometric properties of the CVLT such as difficulty) (L. J. Chapman 
and J. P. Chapman, 1973) and controlling statistically for general ability may not adequately 
address these confounds. On the other hand, self-generated verbal declarative memory 
retrieval may also represent a specific deficit in schizophrenia, over and above the 
generalized deficit.
Controlling for the first principal component of the neuropsychological tasks potentially 
extracted much of the reliable proportions of variance within each performance measure. In 
this case, the group differences would disappear because the variance remaining after 
controlling for the reliable component of variance is the random component. Arguing 
against this interpretation, the first principal component accounted for only 37% of the 
variance in test performance overall, and the loadings of individual test on the general ability 
factor were all below 0.30. Given that the reliabilities of the measures from each of the tests 
used are generally 0.75 or above, the first principal component would appear to account for 
less than half of the reliable variance in each measure.
Memory-related dysfunction does not appear to represent an area of substantial overlap 
between schizophrenia and bipolar disorder or ADHD, though both can present with 
memory-related impairments. BP did demonstrate impairment across the memory tasks; 
however, these were at most intermediate to the deficits found in SCZ. BP showed moderate 
impairments relative to controls on some tasks; however, similar to SCZ, there did not 
appear to be specific subgroups of BP that accounted for most of the impairments. Contrary 
to our hypothesis and some previous findings (Glahn et al., 2006), a history of psychotic 
features did not reliably differentiate BP on any task or on the general memory component. 
However, given the overall sample size and the limited number of BP subjects with current 
psychotic symptoms, this study was likely underpowered to detect group differences. 
Furthermore, this study’s reliance on lifetime history and self-report may have reduced 
sensitivity to effects associated with psychosis in BP as more recent findings show that 
greater cognitive impairment tends to be associated with more significant psychosis and 
fewer affective symptoms (Hill et al., 2013). Adults with a history of ADHD may show 
some relative problems with memory, especially visuospatial memory capacity and 
maintenance (Martinussen et al., 2005), though these may be more specifically related to 
goal-directed activity (Castel et al., 2011). These tasks did not contain specific reward 
components and so may not be as sensitive to that aspect of cognitive impairment in ADHD.
This study was not designed to determine the sources of cognitive deficits in schizophrenia; 
other research suggests that memory deficits are present early in the illness (Bilder et al., 
2000) and during the prodromal phase (Seidman et al., 2010), suggesting that they correlate 
with factors involved in pathophysiology rather than secondary phenomena. The inclusion 
of a very large community reference sample provides a strong basis with which to represent 
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the normal distribution of performance on these tasks. This and the similarity to published 
norms (Norman et al., 2000) suggests it is unlikely that the group differences detected in this 
study are due to over-sampling of high functioning healthy individuals. The smaller sizes of 
the patient groups means that we may not have sampled the full performance distribution in 
the patients and may not be able to detect subtle differences in the underlying cognitive 
structure (Lam et al., 2014). However, our results did not differ when factor loadings were 
derived from controls alone. Furthermore, the effect sizes in this study generally match those 
in the literature (Heinrichs and Zakzanis, 1998) and a previous study utilizing a very large 
sample of schizophrenia patients reported similar PCA results (Keefe et al., 2006).
In conclusion, schizophrenia appears to involve a deficit in general ability that manifests 
across multiple tasks, rather than deficits within specific memory domains and modalities 
per se. Further, the overall distribution of general ability is shifted lower among patients 
with schizophrenia (i.e., with each case functioning at a lower level than they would have if 
not for the illness), rather than group differences being driven by a subgroup of patients. As 
the focus of this study was on memory systems, we did not include tasks designed to isolate 
subcomponents of other domains of cognition of relevance to schizophrenia. Further 
research is needed to determine whether patient deficits in these other domains, including 
perception, attention, executive function, and affective processing are also accounted for by 
the generalized deficit.
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Figure 1. 
Density plots of the distribution of memory performance for each group on a representative 
subset of the measures. Distributions are represented as the proportion of each sample 
falling in a given range using a Gaussian kernel density curve to facilitate comparisons 
across groups despite sample size differences. Three neuropsychological and three 
cognitive/experimental measures are shown covering verbal episodic memory and spatial 
and verbal working memory. The primary measures for comparison were the total raw score 
for the CVLT, Symbol Span and Digit Span and d-prime for the Remember-Know, Spatial 
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Capacity (SCAP), and Verbal Maintenance (VMNM – Maintenance) measures. Performance 
on each task was scaled (M=0, SD=1) across all participants.
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Figure 2. 
Density plots showing the scores of the groups on the first principal component and residual 
performance variance within groups after removing that component on a representative 
subset of the measures. Three neuropsychological and three cognitive/experimental 
measures are shown covering verbal episodic memory and spatial and verbal working 
memory. The primary measures for comparison were the total raw score for the CVLT, 
Symbol Span and Digit Span and d-prime for the Remember-Know, Spatial Capacity 
(SCAP), and Verbal Maintenance (VMNM – Maintenance) measures.
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